RKDA:NASDAQ
Arcadia Biosciences Inc
$1.00
arrow_downward
-3.38%(-0.035) 1D
Jun 5, 2:13:29 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RKDA...
Open
$1.00
High
$1.04
Low
$0.94
Mkt. cap
2.06M
Avg. vol.
2.12M
Volume
68.32K
52-wk high
$6.71
52-wk low
$0.80
EPS
-$5.72
Beta
0.51
Shares outstanding
2.06M
No. of employees
8
Open
$1.00
High
$1.04
Low
$0.94
Mkt. cap
2.06M
Avg. vol.
2.12M
Volume
68.32K
52-wk high
$6.71
52-wk low
$0.80
EPS
-$5.72
Beta
0.51
Shares outstanding
2.06M
No. of employees
8
News stories
From sources across the web
qz.com
·
5 minutes ago
AstraZeneca CEO on firm's transfer to NYSE
Seeking Alpha
·
1 hour ago
Nasdaq-100 falls more than 3% as Arm, AMD, and Micron lead the broad tech selloff
Simply Wall Street
·
39 minutes ago
Biogen’s Salanersen Win Adds New Dimension To SMA Growth Story
Bloomberg.com
·
20 hours ago
SpaceX, Other Mega IPOs Denied Fast Index Entry by S&P
Profile
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought. Wikipedia
About Arcadia Biosciences Inc
AI content may include mistakes. Learn more